Article    Correction    Table of Contents                    Full Text of this article Free    PDF of this article (PDFs free after 6 months)    Summary for Patients    Summary for Patients (PDF) All Versions of this Article:    141/5/381 (most recent)    0000605-200409070-00101v1    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Published comments/rapid response letters    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search                            Get Permissions  Google Scholar    Search for Related Content  PubMed Articles in PubMed by Author:    McAlister, F. A.    Abraham, W.    Related Articles in PubMed    PubMed Citation    PubMed

REVIEW

Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

Finlay A. McAlister, MD, MSc; Justin A. Ezekowitz, MB, BCh, MSc; Natasha Wiebe, Mmath; Brian Rowe, MD, MSc; Carol Spooner, MSc; Ellen Crumley, MLIS; Lisa Hartling, MSc; Terry Klassen, MD, MSc; and William Abraham, MD

7 September 2004 | Volume 141 Issue 5 | Pages 381-390

Background: Even with optimal pharmacotherapy, symptomatic heart failure is associated with substantial morbidity and mortality.

Purpose: To determine the efficacy and safety of cardiac resynchronization therapy in adults with advanced systolic heart failure.

Data Sources: The Cochrane Central Register of Controlled Trials (2002, volume 4), MEDLINE (1980–2003), EMBASE (1980–2003), other electronic databases, and U.S. Food and Drug Administration reports. We contacted primary study authors and device manufacturers, and we hand searched bibliographies of relevant papers and conference proceedings.

Study Selection: Randomized, controlled clinical trials for efficacy and controlled trials plus prospective cohort studies for safety.

Data Extraction: Two reviewers chose studies and extracted data independently; random-effects models were used for analyses.

Data Synthesis: Nine trials were included in the efficacy review (3216 patients). All trial participants had reduced ejection fraction and prolonged QRS duration, and 85% had New York Heart Association (NYHA) class III or IV symptoms. Cardiac resynchronization therapy improved ejection fraction (weighted mean difference, 0.035 [95% CI, 0.015 to 0.055]), quality of life (weighted mean reduction in score on the Minnesota Living with Heart Failure Questionnaire, 7.6 points [CI, 3.8 to 11.5 points]), and function (58% vs. 37% of patients improved by at least 1 NYHA class). Heart failure hospitalizations were reduced by 32% (relative risk [RR], 0.68 [CI, 0.41 to 1.12]), with benefits most marked in patients with NYHA class III or IV symptoms at baseline (RR, 0.65 [CI, 0.48 to 0.88]; number needed to treat for benefit [NNT_B], 12). All-cause mortality was reduced by 21% (RR, 0.79 [CI, 0.66 to 0.96]; NNT_B, 24), driven largely by reductions in death from progressive heart failure (RR, 0.60 [CI, 0.36 to 1.01]). Eighteen studies (total of 3701 patients with cardiac resynchronization devices) were included in the safety review. Implant success rate was 90% (CI, 89% to 91%), and 0.4% of patients died during implantation (CI, 0.2% to 0.7%). Over a median 6-month follow-up, leads dislodged in 9% of patients (CI, 7% to 10%) and mechanical malfunctions occurred in 7% (CI, 5% to 8%).

Limitations: These trials enrolled only patients with heart failure with NYHA class III or IV symptoms despite medical therapy, a prolonged QRS duration, and reduced ejection fraction; in addition, experienced providers implanted the devices. Because all but one of these trials randomly assigned patients after device implantation, their results may overestimate the potential benefits of cardiac resynchronization. Finally, since few patients in these trials had bradyarrhythmias or atrial fibrillation, the role of cardiac resynchronization in such patients is uncertain.

Conclusions: In selected patients with heart failure, cardiac resynchronization therapy improves functional and hemodynamic status, reduces heart failure hospitalizations, and reduces all-cause mortality.

Editors' Notes Context A biventricular pacemaker to resynchronize ventricular contraction is a new therapy for heart failure. A 2003 meta-analysis included only 2 published and 2 unpublished trials, but 5 additional studies have since become available. Contribution Data from 3216 patients who participated in 9 trials demonstrate that cardiac resynchronization improves many outcomes, including mortality. Data from 3701 patients participating in 18 studies showed that leads dislodged in 9% of patients during 6 months of follow-up and that the device malfunctioned in 7%. Implications In select patients, cardiac resynchronization is an effective therapy for heart failure. –The Editors

 

Author and Article Information

From The University of Alberta and Capital Health Evidence-based Practice Center, Edmonton, Alberta, Canada; and Ohio State University, Columbus, Ohio.

Acknowledgments: The authors thank the following individuals, who provided data from their studies: Drs. S. Cazeau, C. Leclerq, and S. Garrigue. The authors also thank the reviewers of the AHRQ report from which this manuscript is derived: Drs. Joanne Siegel and David Atkins (AHRQ), Dr. Bruce Wilkoff (Cleveland Clinic Foundation, Cleveland, Ohio), Dr. Donald Casey (Catholic Healthcare Partners, Cincinnati, Ohio), Dr. Robert Rea (Mayo Clinic, Rochester, Minnesota), Dr. Robert Kowal (University of Texas Southwestern Medical Center, Dallas, Texas), and Dr. Clyde Yancy (St. Paul University Hospital/University of Texas Southwestern Medical Center, Dallas, Texas).

Grant Support: The evidence report was produced by the University of Alberta Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (contract no. 290-02-0023). Dr. McAlister is supported by the Alberta Heritage Foundation for Medical Research, Drs. Ezekowitz and McAlister are supported by the Canadian Institutes of Health Research, and Dr. Rowe is supported by a Canada Research Chair.

Potential Financial Conflicts of Interest:Honoraria: W. Abraham (Medtronic Inc., Guidant Corp., St. Jude Memorial); Grants: W. Abraham (Medtronic Inc., Guidant Corp.).

Requests for Single Reprints: Finlay A. McAlister, MD, MSc, 2E3.24, University of Alberta Hospital, 8440 112 Street, Edmonton, Alberta T6G 2R7, Canada; e-mail, Finlay.McAlister{at}ualberta.ca.

Current Author Addresses: Dr. McAlister: 2E3.24, University of Alberta Hospital, 8440 112 Street, Edmonton, Alberta T6G 2R7, Canada.

Dr. Ezekowitz: University of Alberta, 2-51 Medical Sciences Building, Edmonton, Alberta T6G 2H7, Canada.

Ms. Wiebe and Ms. Hartling: University of Alberta Campus, 9417 Aberhart Centre One, 11402 University Avenue, Edmonton, Alberta T6G 2J3, Canada.

Dr. Rowe: Division of Emergency Medicine, University of Alberta Hospital, 8440 112 Street, Edmonton, Alberta T6G 2R7, Canada.

Ms. Spooner: University of Alberta, Room 1814, 8215 112 Street, Edmonton, Alberta T6G 2C8, Canada.

Ms. Crumley: University of Alberta Campus, 9419 Aberhart Centre One, 11402 University Avenue, Edmonton, Alberta T6G 2J3, Canada.

Dr. Klassen: Department of Pediatrics, University of Alberta Hospital, 8440 112 Street, Edmonton, Alberta T6G 2R7, Canada.

Dr. Abraham: Ohio State University, 473 West 12th Avenue, Columbus, OH 43210.

Related articles in Annals:

Articles
Cost-Effectiveness of Cardiac Resynchronization Therapy in Patients with Symptomatic Heart Failure
Graham Nichol, Padma Kaul, Ella Huszti, AND John F.P. Bridges

Annals 2004 141: 343-351. [ABSTRACT][SUMMARY][Full Text]  

Editorials
Cardiac Resynchronization for Heart Failure
Mark A. Hlatky AND Barry M. Massie

Annals 2004 141: 399-400. [Full Text]  

Summaries for Patients
Cardiac Resynchronization Therapy for Heart Failure

Annals 2004 141: I-64. [Full Text]  

Letters
Cardiac Resynchronization Therapy in Heart Failure
Enrique V. Carbajal, Grace W. Huang, AND Billy Hu

Annals 2005 142: 305. [Full Text]  

Letters
Cardiac Resynchronization Therapy in Heart Failure
Melanie Calvert, Nick Freemantle, AND John G.F. Cleland

Annals 2005 142: 305-307. [Full Text]  

Letters
Cardiac Resynchronization Therapy in Heart Failure
Finlay A. McAlister, Natasha Wiebe, AND William Abraham

Annals 2005 142: 307-308. [Full Text]  

Letters
Correction: Cardiac Resynchronization in Patients with Symptomatic Heart Failure

Annals 2005 142: 311. [Full Text]  

This article has been cited by other articles:

				G. Z. Duray, C. W. Israel, D. Pajitnev, and S. H. Hohnloser Upgrading to biventricular pacing/defibrillation systems in right ventricular paced congestive heart failure patients: prospective assessment of procedural parameters and response rate Europace, January 1, 2008; 10(1): 48 - 52. [Abstract] [Full Text] [PDF]

				C. Leclercq, G. B. Bleeker, C. Linde, E. Donal, J. J. Bax, M. J. Schalij, and C. Daubert Cardiac resynchronization therapy: clinical results and evolution of candidate selection Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I94 - I106. [Abstract] [Full Text] [PDF]

				S. K H Lam and A. Owen Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials BMJ, November 3, 2007; 335(7626): 925 - 925. [Abstract] [Full Text] [PDF]

				M. B. Sharifkazemi and A. Aslani Stabilization of the coronary sinus lead position with permanent stylet to prevent and treat dislocation Europace, October 1, 2007; 9(10): 875 - 877. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Europace, October 1, 2007; 9(10): 959 - 998. [Full Text] [PDF]

				Authors/Task Force Members, P. E. Vardas, A. Auricchio, J.-J. Blanc, J.-C. Daubert, H. Drexler, H. Ector, M. Gasparini, C. Linde, F. B. Morgado, et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in Collaboration with the European Heart Rhythm Association Eur. Heart J., September 2, 2007; 28(18): 2256 - 2295. [Full Text] [PDF]

				S. H. Hohnloser and E. N. Prystowsky CRT-D use in heart failure: too little or too much? Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G9 - G16. [Abstract] [Full Text] [PDF]

				K. L. Lee, C.-P. Lau, H.-F. Tse, D. S. Echt, D. Heaven, W. Smith, and M. Hood First Human Demonstration of Cardiac Stimulation With Transcutaneous Ultrasound Energy Delivery: Implications for Wireless Pacing With Implantable Devices J. Am. Coll. Cardiol., August 28, 2007; 50(9): 877 - 883. [Abstract] [Full Text] [PDF]

				M. J. Haykowsky, Y. Liang, D. Pechter, L. W. Jones, F. A. McAlister, and A. M. Clark A Meta-Analysis of the Effect of Exercise Training on Left Ventricular Remodeling in Heart Failure Patients: The Benefit Depends on the Type of Training Performed J. Am. Coll. Cardiol., June 19, 2007; 49(24): 2329 - 2336. [Abstract] [Full Text] [PDF]

				F. A. McAlister, J. Ezekowitz, N. Hooton, B. Vandermeer, C. Spooner, D. M. Dryden, R. L. Page, M. A. Hlatky, and B. H. Rowe Cardiac Resynchronization Therapy for Patients With Left Ventricular Systolic Dysfunction: A Systematic Review JAMA, June 13, 2007; 297(22): 2502 - 2514. [Abstract] [Full Text] [PDF]

				G. Truin, A. Backx, H. van Wetten, and C. Neeleman Cardiac Resynchronization Therapy for Mitral Systolic Anterior Motion in a Child Ann. Thorac. Surg., May 1, 2007; 83(5): 1873 - 1874. [Abstract] [Full Text] [PDF]

				J. D. Burkhardt and B. L. Wilkoff Interventional Electrophysiology and Cardiac Resynchronization Therapy: Delivering Electrical Therapies for Heart Failure Circulation, April 24, 2007; 115(16): 2208 - 2220. [Abstract] [Full Text] [PDF]

				B. Greenberg and M. R. Mehra All Patients With Heart Failure and Intraventricular Conduction Defect or Dyssynchrony Should Not Receive Cardiac Resynchronization Therapy Circulation, December 12, 2006; 114(24): 2685 - 2691. [Full Text] [PDF]

				M. Rivero-Ayerza, D. A.M.J. Theuns, H. M. Garcia-Garcia, E. Boersma, M. Simoons, and L. J. Jordaens Effects of cardiac resynchronization therapy on overall mortality and mode of death: a meta-analysis of randomized controlled trials Eur. Heart J., November 2, 2006; 27(22): 2682 - 2688. [Abstract] [Full Text] [PDF]

				F. Braunschweig Devices in heart failure: building up the evidence Eur. Heart J., November 2, 2006; 27(22): 2617 - 2618. [Full Text] [PDF]

				J. McMurray and K. Swedberg Treatment of chronic heart failure: a comparison between the major guidelines Eur. Heart J., August 1, 2006; 27(15): 1773 - 1777. [Abstract] [Full Text] [PDF]

				J. A. Jarcho Biventricular pacing. N. Engl. J. Med., July 20, 2006; 355(3): 288 - 294. [Full Text] [PDF]

				E. Donal, C. Leclercq, C. Linde, and J.-C. Daubert Effects of cardiac resynchronization therapy on disease progression in chronic heart failure Eur. Heart J., May 1, 2006; 27(9): 1018 - 1025. [Abstract] [Full Text] [PDF]

				W. C. Levy, D. Mozaffarian, D. T. Linker, S. C. Sutradhar, S. D. Anker, A. B. Cropp, I. Anand, A. Maggioni, P. Burton, M. D. Sullivan, et al. The Seattle Heart Failure Model: Prediction of Survival in Heart Failure Circulation, March 21, 2006; 113(11): 1424 - 1433. [Abstract] [Full Text] [PDF]

				C Philippe, M Stoica-Herman, X Drouot, B Raffestin, P Escourrou, L Hittinger, P-L Michel, S Rouault, and M-P d'Ortho Compliance with and effectiveness of adaptive servoventilation versus continuous positive airway pressure in the treatment of Cheyne-Stokes respiration in heart failure over a six month period Heart, March 1, 2006; 92(3): 337 - 342. [Abstract] [Full Text] [PDF]

				F. A. McAlister, J. V. Tu, A. Newman, D. S. Lee, S. Kimber, B. Cujec, and P. W. Armstrong How many patients with heart failure are eligible for cardiac resynchronization? Insights from two prospective cohorts Eur. Heart J., February 1, 2006; 27(3): 323 - 329. [Abstract] [Full Text] [PDF]

				J. C. Daubert, C. Leclercq, and P. Mabo There Is Plenty of Room for Cardiac Resynchronization Therapy Devices Without Back-Up Defibrillators in the Electrical Treatment of Heart Failure J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2204 - 2207. [Abstract] [Full Text] [PDF]

				C. Ermis, R. Seutter, A. X. Zhu, L. C. Benditt, L. VanHeel, S. Sakaguchi, K. G. Lurie, F. Lu, and D. G. Benditt Impact of Upgrade to Cardiac Resynchronization Therapy on Ventricular Arrhythmia Frequency in Patients With Implantable Cardioverter-Defibrillators J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2258 - 2263. [Abstract] [Full Text] [PDF]

				A. M. Feldman, G. de Lissovoy, M. R. Bristow, L. A. Saxon, T. De Marco, D. A. Kass, J. Boehmer, S. Singh, D. J. Whellan, P. Carson, et al. Cost Effectiveness of Cardiac Resynchronization Therapy in the Comparison of Medical Therapy, Pacing, and Defibrillation in Heart Failure (COMPANION) Trial J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2311 - 2321. [Abstract] [Full Text] [PDF]

				M. A. Hlatky Cost Effectiveness of Cardiac Resynchronization Therapy J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2322 - 2324. [Full Text] [PDF]

				M. J. Calvert, N. Freemantle, G. Yao, J. G.F. Cleland, L. Billingham, J.-C. Daubert, S. Bryan, and on behalf of the CARE-HF Investigators Cost-effectiveness of cardiac resynchronization therapy: results from the CARE-HF trial Eur. Heart J., December 2, 2005; 26(24): 2681 - 2688. [Abstract] [Full Text] [PDF]

				A. Kadish and M. Mehra Heart Failure Devices: Implantable Cardioverter-Defibrillators and Biventricular Pacing Therapy Circulation, June 21, 2005; 111(24): 3327 - 3335. [Full Text] [PDF]

				L. Hartling, F. A. McAlister, B. H. Rowe, J. Ezekowitz, C. Friesen, and T. P. Klassen Challenges in Systematic Reviews of Therapeutic Devices and Procedures Ann Intern Med, June 21, 2005; 142(12_Part_2): 1100 - 1111. [Abstract] [Full Text] [PDF]

				R. H. Helm, C. Leclercq, O. P. Faris, C. Ozturk, E. McVeigh, A. C. Lardo, and D. A. Kass Cardiac Dyssynchrony Analysis Using Circumferential Versus Longitudinal Strain: Implications for Assessing Cardiac Resynchronization Circulation, May 31, 2005; 111(21): 2760 - 2767. [Abstract] [Full Text] [PDF]

				J. A. Jarcho Resynchronizing Ventricular Contraction in Heart Failure N. Engl. J. Med., April 14, 2005; 352(15): 1594 - 1597. [Full Text] [PDF]

				J. G.F. Cleland, J.-C. Daubert, E. Erdmann, N. Freemantle, D. Gras, L. Kappenberger, L. Tavazzi, and the Cardiac Resynchronization -- Heart Failure (CA The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure N. Engl. J. Med., April 14, 2005; 352(15): 1539 - 1549. [Abstract] [Full Text] [PDF]

				ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., April 1, 2005; 10(2): 62 - 62. [Full Text] [PDF]

				E. V. Carbajal, G. W. Huang, and B. Hu Cardiac Resynchronization Therapy in Heart Failure Ann Intern Med, February 15, 2005; 142(4): 305 - 305. [Full Text] [PDF]

				Correction: Cardiac Resynchronization in Patients with Symptomatic Heart Failure Ann Intern Med, February 15, 2005; 142(4): 311 - 311. [Full Text] [PDF]

				M. Calvert, N. Freemantle, and J. G.F. Cleland Cardiac Resynchronization Therapy in Heart Failure Ann Intern Med, February 15, 2005; 142(4): 305 - 307. [Full Text] [PDF]

				Cardiac Resynchronization Therapy: A Meta-Analysis Journal Watch Cardiology, October 22, 2004; 2004(1022): 2 - 2. [Full Text]

				Cardiac Resynchronization for Heart Failure: Effective but Costly Journal Watch (General), October 1, 2004; 2004(1001): 2 - 2. [Full Text]

				M. A. Hlatky and B. M. Massie Cardiac Resynchronization for Heart Failure Ann Intern Med, September 7, 2004; 141(5): 399 - 400. [Full Text] [PDF]

Rapid Responses: